• Home
  • Tech transfer

Tech transfer

In applied research, IOCB’s long tradition of translating results of basic research into products that help people live better lives continues to this day. We have established a dedicated applied research infrastructure that consists of several internal spinoffs.

Since 2009, technology transfer, applications, and IP protection have been coordinated by IOCB Tech and later also by i&i Prague. These IOCB subsidiary companies are recognized throughout Czechia as leading commercialization experts for biotech projects and have successfully attracted local and global investment groups and funds largely thanks to the current vice-director for strategic development, Prof. Martin Fusek, founder of technology transfer at IOCB.

An image with a timeline depicting the registration of some of the drugs resulting from IOCB research. More about these drugs can be found in the article Successful IOCB compounds – link follows.
Some of the registered drugs with active compounds originating from IOCB